A study for a 64 year old woman who takes Omacor, Plendil, Arimidex, Flax Seed - from FDA reports


Summary

27 females aged 64 (±5) who take the same drugs are studied. This is a personalized study for a 64 year old female patient who has Nsvt, Breast Cancer Stage I, Vitamin Supplementation. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Nov, 16, 2017

27 females aged 64 (±5) who take Omacor, Plendil, Arimidex, Flax Seed are studied.


Number of reports submitted per year:

Omacor, Plendil, Arimidex, Flax Seed for a 64-year old woman.

Information of the patient in this study:

  • Age: 64
  • Gender: female
  • Conditions: Nsvt, Breast Cancer Stage I, Vitamin Supplementation
  • Drugs taken:
    • Omacor (omega-3acid ethyl esters)
    • Plendil (felodipine)
    • Arimidex (anastrozole)
    • Flax Seed (flaxseed)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Gouty Arthritis: 0 (0% of females aged 64 (±5) who take the drugs)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common drug interactions over time

< 1 month:
  • abnormal faeces
  • rash macular
  • neck pain
  • hot flush
  • pain
  • pain in extremity
1 - 6 months:
n/a
6 - 12 months:
n/a
1 - 2 years:
n/a
2 - 5 years:
n/a
5 - 10 years:
n/a
10+ years:
n/a
not specified:
  • insomnia
  • chest pain
  • pleural effusion
  • tooth loss
  • osteonecrosis of jaw
  • mitral valve incompetence
  • joint pain
  • pain
  • head injury
  • weakness

Top conditions involved for these people *:

  • Pain (5 people, 18.52%)
  • Osteoporosis (2 people, 7.41%)
  • Dry Eyes (2 people, 7.41%)
  • Breast Cancer Stage Ii (1 person, 3.70%)
  • Blood Potassium Decreased (1 person, 3.70%)

Top co-used drugs for these people *:

  • Atenolol (7 people, 25.93%)
  • Zyrtec (6 people, 22.22%)
  • Zometa (6 people, 22.22%)
  • Nystatin (5 people, 18.52%)
  • Metronidazole (5 people, 18.52%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

What are the symtoms?

Could your drugs cause:

Could your conditions cause:

Related studies:

Can you answer these questions?

More questions for: Nsvt, Flax seed, Arimidex, Gouty arthritis, Vitamin supplementation, Omacor, Plendil, Breast cancer stage i

You may be interested in these reviews

More reviews for: Nsvt, Flax seed, Arimidex, Gouty arthritis, Vitamin supplementation, Omacor, Plendil, Breast cancer stage i